Cboe Files for Triple-Leveraged Bitcoin and Ethereum ETFs in US Market First

Cboe BZX just put 3x on the table. The exchange filed a proposed rule change with the SEC to list six leveraged commodity ETFs, including triple-exposure Bitcoin and Ether products — a first for the US market, where leveraged crypto ETFs have so far capped at 2x.

The structure

Per the filing, the crypto sleeves will hold CME futures, not spot. Volatility Shares LLC acts as sponsor, running the products off its VS Trust platform. The same firm already issues 2x Bitcoin and Ether strategy ETFs in the US. The proposed 3x funds simply extend that template by a full multiple.

The vehicles will be structured as commodity pools, not registered investment companies under the 1940 Act. That pulls in CFTC oversight alongside the SEC review and triggers a Form S-1 registration. Cboe also flagged that the funds fail its standard listing criteria due to leverage — hence the rule-change route.

The math most filings ignore

Triple daily return works both directions. A 5% drop in BTC compounds to a 15% hit on the 3x fund in one session. Two consecutive -5% days equal roughly -27.75%, not the -30% a flat multiple would suggest — that's the volatility drag, and it bites in both directions. These products reset daily. Holding them across weeks means path dependency, not exposure to the underlying trend.

The fundraising reality: the filing exists because European venues already offer 3x and -3x BTC and ETH ETFs. Demand is proven. Liquidity is the open question — US-side book depth on existing 2x crypto ETFs has been thin, and a 3x sleeve requires tighter rebalancing windows to avoid tracking error.

What to watch

• SEC comment period and timeline. Given the recent wave of spot crypto ETF approvals, the bottleneck is likely structural disclosure, not approval theory.
• Sponsor's tracking error disclosures. Volatility Shares will need to publish daily rebalancing mechanics and financing costs. Funding-rate drag on a 3x futures-backed BTC product is materially higher than 2x.
• First-day volumes. The 2x products from this same sponsor provide a baseline. If 3x opens below that benchmark, the institutional bid is thin.
• CFTC coordination. Dual oversight means dual reporting. Any conflict between the two regulators can delay the effective date by quarters.

The product is a trading instrument, not a long-term holding. Anyone allocating capital here should size it like a short-term tactical position, not a core crypto exposure. The filing is submitted. The real question is whether the SEC treats 3x as a step too far, or simply the next logical tier in the leveraged ETF stack.